A Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of BCX17725
A Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of BCX17725
Recruiting · NCT06539507 · Registry updated 2026-08-27Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of BCX17725 | Abnormalities, Multiple, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Ichthyosiform Erythroderma, Congenital, Infant, Newborn, Diseases, Netherton syndrome, Skin Abnormalities, Skin and Connective Tissue Diseases, hereditary disease, hereditary skin disorder, ichthyosis, keratosis, skin disorder | Recruiting | Phase 1 | 2026-08-27 | NCT06539507 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| BioCryst Pharmaceuticals | 3 |
12 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Dawes Fretzin Clinical Research Group, LLC | Indianapolis | United States | 23 |
| Erasmus Universitair Medisch Centrum (EMC) | Rotterdam | Netherlands | 1 |
| Hôpital Saint-Louis | Paris | France | 19 |
| Maastricht Universitair Medisch Centrum (MUMC+) | Maastricht | Netherlands | 1 |
| Northwestern Dermatology CTU | Chicago | United States | 1 |
| Nucleus Network | Brisbane | Australia | 2 |
| Stanford University School of Medicine | Palo Alto | United States | 18 |
| Therapeutics Clinical Research | San Diego | United States | 6 |
| Universitätsklinikum Heidelberg | Heidelberg | Germany | 47 |
| Veracity Clinical Research | Brisbane | Australia | 1 |
| Westmead Hospital - Department of Dermatology | Sydney | Australia | 1 |
| Yale Center for Clinical Investigation | New Haven | United States | 3 |